ConvergEx Group, a provider of investment technologies and execution solutions to institutional clients worldwide, has entered in to a strategic alliance with the Marwood Group, a healthcare advisory and financial services firm based in New York. Through the agreement, clients will be able to use ConvergExs industry-leading execution technologies to generate credits for Marwoods sought after healthcare research.
ConvergEx has committed itself to building imaginative and innovative investment technologies that their clients have come to value tremendously, says Edward Kennedy Jr., President and co-founder of the Marwood Group. We are very pleased to introduce our clients to ConvergEx so they will benefit from the access to Wall Streets largest aggregator of soft-dollars as well as their advanced, global capabilities.
We are honored to be able to form this agreement with the Marwood Group, says Joseph M. Velli, chairman and chief executive officer of ConvergEx Group. Their clients understand the difference high-quality investment products make and we look forward to working with them and offering our customized technologies and services.
D.C.